Integrated Filing — IndAS



General information about company

Scrip Code 507747
NSE Symbol TTKHLTCARE
MSEI Symbol NOTLISTED
ISIN INE910C01018
Name of company TTK HEALTHCARE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 30-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 15-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 30-05-2026   12:00:00
End date and time of board meeting 30-05-2026   13:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 17-10-2025
Indicate Company website link for updated RPT policy of the Company www.ttkhealthcare.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no Default on loans and Debt Securities, hence Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 21,798.47 85,728.11
Other income 1,776.81 7,215.00
Total income 23,575.28 92,943.11
2 Expenses
(a) Cost of materials consumed 5,149.39 20,049.11
(b) Purchases of stock-in-trade 5,329.71 20,305.41
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 141.31 (5.65)
(d) Employee benefit expense 4,099.36 16,516.12
(e) Finance costs 63.76 292.88
(f) Depreciation, depletion and amortisation expense 213.81 875.95
(f) Other Expenses
1 Other Expenses 5,975.81 26,245.54
Total other expenses 5,975.81 26,245.54
Total expenses 20,973.15 84,279.36
3 Total profit before exceptional items and tax 2,602.13 8,663.75
4 Exceptional items 350.42 (407.45)
5 Total profit before tax 2,952.55 8,256.30
6 Tax expense
7 Current tax 750.00 1,728.48
8 Deferred tax 26.34 (40.23)
9 Total tax expenses 776.34 1,688.25
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,176.21 6,568.05
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 2,176.21 6,568.05
17 Other comprehensive income net of taxes (217.48) (174.80)
18 Total Comprehensive Income for the period 1,958.73 6,393.25
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,413.03 1,413.03
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,09,630.58
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 15.4 46.48
Diluted earnings (loss) per share from continuing operations 15.4 46.48
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 15.4 46.48
Diluted earnings (loss) per share from continuing and discontinued operations 15.4 46.48
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: (1) The above financial results for the Fourth Quarter and Year ended March 31, 2026 in respect of TTK Healthcare Limited (the Company) have been reviewed by the Audit Committee at its meeting held on May 29, 2026 and approved by the Board of Directors of the Company at its meeting held on May 30, 2026 at the Registered Office of the Company, also with the provision of Video Conferencing facility. The Statutory Auditors have audited the above results and have issued an unmodified opinion. (2) On November 21, 2025, the Government of India notified the four Labour Codes, consolidating 29 existing labour laws, and the Ministry of Labour & Employment subsequently issued draft Central Rules and FAQs. Based on the best information presently available and in line with the guidance issued by the Institute of Chartered Accountants of India, the Company has assessed the incremental impact arising from the change in the definition of wages and, considering its material, regulatory-driven and non-recurring nature, has presented the same as Exceptional items in the Statement of Profit and Loss for the year ended March 31, 2026. The incremental impact comprises of Gratuity of Rs.823.02 lakhs and Long-term Compensated Absences of Rs.284.85 lakhs, against which a provision of Rs.350 lakhs created in FY 2020–21 has been adjusted, resulting in a net charge of Rs.757.87 lakhs recognised in the Third Quarter of the current financial year. The Company continues to monitor the developments pertaining to Labour Codes and will evaluate impact if any on the measurement of liability pertaining to employee benefits including that of contract workforce. The Company is in the process of revising the Wage Structure in FY 2026–27 and would provide appropriate accounting treatment as and when it is finalized. (3)The Company has recognised Rs.350.41 lakhs as exceptional income during the fourth quarter of the current year towards GST refund relating to earlier periods, which was received subsequently. (4)Exceptional Items pertaining to Previous year: (a)During the First Quarter of the previous year, the Company had sold Leasehold land with building at Mahindra World City, Chennai for a consideration of Rs.2,300 lakhs and the profit on sale amounting to Rs.1,977.05 lakhs (Net) has been considered in the above results. (b)During the Fourth Quarter of the previous year, the Company had written off the entire value of Male Contraceptives pertaining to the Protective Devices Division amounting to Rs.586.39 lakhs that were meant for export under USAID Program, owing to a 90-day pause on foreign development assistance and subsequent cancellation of Purchase Orders as the inventory was custom-made and not marketable to alternate buyers. (5)The tax relating to earlier years represents the tax refund relating to AY 2016-17 & AY 2017-18 received, consequent to completion of assessments. (6)The Board has recommended a dividend of Rs.10/- (100%) per Equity Share of Rs.10/- each for the financial year ended March 31, 2026. (7)The figures for the Quarter ended March 31, 2026 and March 31, 2025 are the balancing figures between the Audited Figures in respect of the full financial year and the published year to date figures upto the end of the Third Quarter of the relevant financial year which were subjected to limited review. (8)The previous period's / year's figures have been regrouped and reclassified, wherever necessary to conform to the current period's / year's presentation. (9)This statement is also available on the website of BSE Limited (www.bseindia.com), National Stock Exchange of India Limited (www.nseindia.com) and also on the website of the Company (www.ttkhealthcare.com).



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 7,267.28
Capital work-in-progress 136.79
Investment property
Goodwill 0.00
Other intangible assets 0.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 865.56
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other Financial Assets 1,397.74
Total of other non-current financial assets 1,397.74
Total non-current financial assets 2,263.30
Deferred tax assets (net) 606.78
Other non-current assets
1 Non-current Tax Assets (Net) 739.64
2 Other non-current assets 70.43
Total of other non-current assets 810.07
Total non-current assets 11,084.22
2 Current assets
Inventories 10,871.72
Current financial asset
Current investments 0.00
Trade receivables, current 11,066.31
Cash and cash equivalents 2,188.14
Bank balance other than cash and cash equivalents 61,158.78
Loans, current 0.00
Other current financial assets
Total of other current financial assets 34,145.59
Total current financial assets 1,08,558.82
Current tax assets (net) 2,359.49
Other current assets
Total of other current assets
Total current assets 1,21,790.03
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,32,874.25
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,413.03
Other equity 1,10,072.01
Total equity attributable to owners of parent 1,11,485.04
Non controlling interest
Total equity 1,11,485.04
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 197.92
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities 197.92
Provisions, non-current 567.83
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 765.75
Current liabilities
Current financial liabilities
Borrowings, current 2,190.39
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,206.82
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 6,923.55
Total Trade payable 9,130.37
Other current financial liabilities
1 Other current financial liabilities 5,668.35
2 Lease Liabilities 49.48
Total of other current financial liabilities 5,717.83
Total current financial liabilities 17,038.59
Other current liabilities 370.15
1 Other current liabilities 370.15
Total of other current liabilities 370.15
Provisions, current 2,486.50
Current tax liabilities (Net) 728.22
Deferred government grants, Current 0.00
Total current liabilities 20,623.46
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 21,389.21
Total equity and liabilites 1,32,874.25
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Animal Welfare 3,581.35 14,108.37
2 Consumer Products 5,396.55 24,127.82
3 Medical Devices 2,693.75 10,691.69
4 Protective Devices 6,098.47 21,650.81
5 Foods 4,019.26 15,109.96
6 Others 0.0000909 0.0003946
Total Segment Revenue 21,798.47 85,728.11
Less: Inter segment revenue
Revenue from operations 21,798.47 85,728.11
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Animal Welfare 245.56 1,192.15
2 Consumer Products 528.78 1,835.15
3 Medical Devices 349.26 2,254.24
4 Protective Devices 625.16 (1,054.25)
5 Foods 329.24 1,343.29
6 Others 8.91 40.16
Total Profit before tax 2,086.91 5,610.74
i. Finance cost 63.76 292.88
ii. Other Unallocable Expenditure net off Unallocable income (929.40) (2,938.44)
Profit before tax 2,952.55 8,256.30
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Animal Welfare 4,396.46 4,396.46
2 Consumer Products 5,048.95 5,048.95
3 Medical Devices 8,189.43 8,189.43
4 Protective Devices 14,805.10 14,805.10
5 Foods 5,254.91 5,254.91
6 Others 299.17 299.17
Total Segment Asset 37,994.02 37,994.02
Un-allocable Assets 94,880.23 94,880.23
Net Segment Asset 1,32,874.25 1,32,874.25
4 Segment Liabilities
Segment Liabilities
1 Animal Welfare 2,923.98 2,923.98
2 Consumer Products 5,144.44 5,144.44
3 Medical Devices 1,492.39 1,492.39
4 Protective Devices 4,629.67 4,629.67
5 Foods 1,508.26 1,508.26
6 Others 142.14 142.14
Total Segment Liabilities 15,840.88 15,840.88
Un-allocable Liabilities 5,548.33 5,548.33
Net Segment Liabilities 21,389.21 21,389.21
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) Notes 1. Segments have been identified in line with the Indian Accounting Standard on Segment Reporting (Ind AS 108) based on review of performance by the Top Management. 2. Details of products included in each of the Segments are as below Animal Welfare comprise products for Veterinary use. Consumer Products comprise marketing and distribution of Woodward's Gripewater, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners, etc. Medical Devices include Artificial Heart Valves, Orthopaedic Implants, etc. Protective Devices comprise manufacturing and marketing of Male Contraceptives and other allied products. Foods comprise manufacturing and marketing of Food Products. Others include Printing and Publishing of Maps and Atlases. 3. The segment wise revenue, results, assets and liabilities figures relate to respective amounts directly identifiable to each of the segments. The unallocable expenditure includes expenses incurred on common services at the corporate level and also those expenses not identifiable to any specific segment. 4. The previous periods or years figures have been regrouped and reclassified, wherever necessary to conform to the current periods or years presentation.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified subsequently to profit or loss (190.58) (146.27)
Total Amount of items that will not be reclassified to profit and loss (190.58) (146.27)
2 Income tax relating to items that will not be reclassified to profit or loss 26.90 28.53
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (217.48) (174.80)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 8,256.30
Adjustments for reconcile profit (loss)
Adjustments for finance costs 292.88
Adjustments for decrease (increase) in inventories (12.86)
Adjustments for decrease (increase) in trade receivables, current (2,016.92)
Adjustments for decrease (increase) in trade receivables, non-current (866.60)
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (1,536.22)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 1,170.08
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 875.95
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss (162.09)
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (14.79)
Adjustments for dividend income 10.86
Adjustments for interest income 6,924.18
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 132.48
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (9,073.13)
Net cash flows from (used in) operations (816.83)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,297.99
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (2,114.82)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 30.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 221.33
Purchase of property, plant and equipment 580.23
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 10.86
Interest received 6,750.88
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (1,214.93)
Net cash flows from (used in) investing activities 5,157.91
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 3.12
Payments of lease liabilities 0.00
Dividends paid 1,413.03
Interest paid 283.10
Income taxes paid (refund) 56.34
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (1,755.59)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 1,287.50
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 1,287.50
Cash and cash equivalents cash flow statement at beginning of period 900.64
Cash and cash equivalents cash flow statement at end of period 2,188.14





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 PKF Sridhar & Santhanam LLP Yes 31-10-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 TTK HEALTHCARE LIMITED T T KRISHNAMACHARI AND CO. Promoter and Two of the Directors are interested as Partners Any other transaction Payment of Logo Charges 600.00 Approved 256.69 (83.83) (86.18) Textual Information(1)
2 TTK HEALTHCARE LIMITED T T KRISHNAMACHARI AND CO. Promoter and Two of the Directors are interested as Partners Any other transaction Payment of Depot Service Charges 700.00 Approved 286.96 0.00 0.00 Textual Information(2)
3 TTK HEALTHCARE LIMITED T T KRISHNAMACHARI AND CO. Promoter and Two of the Directors are interested as Partners Any other transaction Payment of Rent 200.00 Approved 72.39 40.00 40.00 Textual Information(3)
4 TTK HEALTHCARE LIMITED T T KRISHNAMACHARI AND CO. Promoter and Two of the Directors are interested as Partners Any other transaction Reimbursement of Electricity Charges Approved 20.77 0.00 0.00
5 TTK HEALTHCARE LIMITED PACKWELL PACKAGING PRODUCTS LIMITED Promoter Group - Two of the Directors are interested as Shareholders and one of the Directors is interested as Director Any other transaction Payment of Rent 50.00 Approved 10.62 28.00 28.00 Textual Information(4)
6 TTK HEALTHCARE LIMITED PACKWELL PACKAGING PRODUCTS LIMITED Promoter Group - Two of the Directors are interested as Shareholders and one of the Directors is interested as Director Any other transaction Packaging Charges 200.00 Approved 40.14 (1.08) (1.08) Textual Information(5)
7 TTK HEALTHCARE LIMITED TTK PRESTIGE LIMITED Promoter Group - Three of the Directors are interested as Directors Purchase of goods or services 300.00 Approved 11.26 (123.27) 0.00 Textual Information(6)
8 TTK HEALTHCARE LIMITED T T SRIRAM Promoter Group - One of the Director is interested as Relative Remuneration Approved 6.61 0.00 0.00
9 TTK HEALTHCARE LIMITED RAGHUNATHAN THIRUVALLUR THATTAI Promoter - Executive Chairman (KMP) Remuneration Approved 391.86 0.00 (327.39) Textual Information(7)
10 TTK HEALTHCARE LIMITED SUBRAMANIAM KALYANARAMAN Managing Director and CEO (KMP) Remuneration Approved 223.37 0.00 (113.75) Textual Information(8)
11 TTK HEALTHCARE LIMITED BHAGAVATULA VENKATAKANAKA DURGAPRASAD President - Finance (CFO) (KMP) Remuneration Approved 83.25 0.00 0.00
12 TTK HEALTHCARE LIMITED GOWRY A JAISHANKAR DGM - Legal & Company Secretary (KMP) Remuneration Approved 12.95 0.00 0.00
13 TTK HEALTHCARE LIMITED RAJIV TULSHAN Director Any other transaction Sitting Fees Approved 2.80 0.00 0.00
14 TTK HEALTHCARE LIMITED KRISHNAMURTHY SHANKARAN Director Any other transaction Sitting Fees Approved 4.40 0.00 0.00
15 TTK HEALTHCARE LIMITED RAMESH RAJAN NATARAJAN Director Any other transaction Sitting Fees Approved 2.40 0.00 0.00
16 TTK HEALTHCARE LIMITED VIJAYARAGHAVACHARI RANGANATHAN Director Any other transaction Sitting Fees Approved 3.20 0.00 0.00
17 TTK HEALTHCARE LIMITED MUKUND THATTAI THIRUVALLUR Promoter Group - Director Any other transaction Sitting Fees Approved 1.60 0.00 0.00
18 TTK HEALTHCARE LIMITED MURALI NEELAKANTAN Director Any other transaction Sitting Fees Approved 2.40 0.00 0.00
19 TTK HEALTHCARE LIMITED HASTHA SHIVARAMAKRISHNAN Director Any other transaction Sitting Fees Approved 2.40 0.00 0.00
20 TTK HEALTHCARE LIMITED SUBASHREE ANANTKRISHNAN Director Any other transaction Sitting Fees Approved 2.80 0.00 0.00
21 TTK HEALTHCARE LIMITED VAITHIANATHAN SUNDARESAN Director Any other transaction Sitting Fees Approved 1.60 0.00 0.00
Total value of transaction during the reporting period 1,440.47



Text Block

Textual Information(1) The value of the Related Party Transaction as approved by the Audit Committee is for the whole year and exclusive of GST. Whereas the actual transaction amount is inclusive of GST. The negative symbol denotes the amounts payable under Opening and Closing balances column.
Textual Information(2) The value of the Related Party Transaction as approved by the Audit Committee is for the whole year and exclusive of GST. Whereas the actual transaction amount is inclusive of GST.
Textual Information(3) The value of the Related Party Transaction as approved by the Audit Committee is for the whole year and exclusive of GST. Whereas the actual transaction amount is inclusive of GST. The Amounts under the Opening and Closing balances column denote the Rent Deposit Receivable.
Textual Information(4) The value of the Related Party Transaction as approved by the Audit Committee is for the whole year and exclusive of GST. Whereas the actual transaction amount is inclusive of GST. The Amounts under the Opening and Closing balances column denote the Rent Deposit Receivable.
Textual Information(5) The value of the Related Party Transaction as approved by the Audit Committee is for the whole year and exclusive of GST. Whereas the actual transaction amount is inclusive of GST. The negative symbol denotes the amounts payable under Opening and Closing balances column.
Textual Information(6) The value of the Related Party Transaction as approved by the Audit Committee is for the whole year and exclusive of GST. Whereas the actual transaction amount is inclusive of GST. The negative symbol denotes the amounts payable under opening balances column.
Textual Information(7) The negative symbol denotes the amount payable under closing balance column.
Textual Information(8) The negative symbol denotes the amount payable under closing balance column.